Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07130786 · ClinicalTrials.gov registry record · Phase 2
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
A Phase 2 study of Seizures and Brain Metastases, Adult, sponsored by Ayal A. Aizer, MD.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT07130786 is a Phase 2 study of Seizures and Brain Metastases, Adult that is actively recruiting participants, run by Ayal A. Aizer, MD. The registered enrollment target is 150 participants, below the 931-participant average among 39 other Seizures trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07130786, a Phase 2 study of Seizures and Brain Metastases, Adult, is actively recruiting participants, sponsored by Ayal A. Aizer, MD.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized trial for patients with brain metastases in the primary motor cortex who have not had seizures to receive either the prophylactic anti-seizure medication levetiracetam (also known by its trade name Keppra) or proceed with standard of care management, which does not currently include prophylactic levetiracetam. Patients who enroll to this trial will be randomized to receive prophylactic levetiracetam or not receive prophylactic levetiracetam.
Conditions Studied
Interventions
- DRUG Levetiracetam (Keppra)
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-12-23 |
| Est. Completion | 2030-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07130786
The ClinicalTrials.gov registry entry for NCT07130786 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 931-participant average among 39 other Seizures trials with a reported enrollment target (84% lower). The listed sponsor is Ayal A. Aizer, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Seizures appearing as the primary indexed condition, and to 1 intervention - of which Levetiracetam (Keppra) is the first listed.
NCT07130786 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07130786 about?
NCT07130786 is a clinical study titled "Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases". This is a randomized trial for patients with brain metastases in the primary motor cortex who have not had seizures to receive either the prophylactic anti-seizure medication levetiracetam (also known by its trade name Keppra) or proceed with standard of care management, which does not currently inc...
What is the current status of trial NCT07130786?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2025-12-23. Estimated completion is 2030-02.
What conditions does trial NCT07130786 study?
This clinical trial studies the following conditions: Seizures, Brain Metastases, Adult, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Metastases From Extra-cranial Solid Tumors, Primary Motor Cortex.
What interventions are being tested in trial NCT07130786?
The interventions under investigation include: Levetiracetam (Keppra) (DRUG).
Who is sponsoring clinical trial NCT07130786?
This trial is sponsored by Ayal A. Aizer, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07130786 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Seizures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
RECRUITING · Phase 2
-
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
RECRUITING · Phase 2
-
RNS System LGS Feasibility Study
ACTIVE NOT RECRUITING · Phase 2
-
Hypovitaminosis D in Neurocritical Patients
COMPLETED · Phase 2
-
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
COMPLETED · Phase 2
-
Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.